ALGS - Aligos Therapeutics, Inc.
Previous close
41.55
-0.170 -0.409%
Share volume: 2,934
Last Updated: Fri 27 Dec 2024 08:21:50 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$41.72
-0.17
-0.41%
Summary score
24%
Profitability
25%
Dept financing
10%
Liquidity
73%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-24.4%
Return on assets
-15.68%
Return on sales
-1957.09%
Return on invested capital
199.67%
Total debt ratio
28.97%
Debt ratio change over timeo
-0.83%
Current Ratio
5.34%
Quick Ratio
5.34%
Cash Position Ratio
5.11%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-37.12%
Return on assets
-18.66%
Return on sales
-1018.09%
Return on invested capital
218.87%
Total debt ratio
40.75%
Debt ratio change over timeo
-0.82%
Current Ratio
4.73%
Quick Ratio
4.73%
Cash Position Ratio
4.53%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-58.3%
Return on assets
-17.24%
Return on sales
-2235.9%
Return on invested capital
385.57%
Total debt ratio
53.25%
Debt ratio change over time
-0.74%
Current Ratio
6.25%
Quick Ratio
6.25%
Cash Position Ratio
5.97%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-114.19%
Return on assets
-109.44%
Return on sales
-1304.37%
Return on invested capital
17.49%
Total debt ratio
-82.7%
Debt ratio change over time
-0.83%
Current Ratio
2.14%
Quick Ratio
2.14%
Cash Position Ratio
1.99%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALGS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -24.4% | 13.79% | 34.47% | 7.43% |
| Return on assets | -15.68% | 2.76% | 3.15% | 5.62% |
| Return on sales | -1957.09% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 199.67% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 58% |
| Total debt ratio | 28.97% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.83% | 308.97% | -6.99% | 1.18% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 4.73% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.73% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 4.53% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 9% | 21% | 48% |
| Short-term ratios | ALGS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -37.12% | 13.77% | 13.25% | 3.8% |
| Return on assets | -18.66% | 2.43% | 1.89% | 3.09% |
| Return on sales | -1018.09% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 218.87% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 40.75% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.82% | 46.38% | -72.08% | 1.51% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 4.73% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.73% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 4.53% | 0.36% | 1.28% | 2.93% |
| Liquididy | 72% | 10% | 27% | 66% |